Monocytic myeloid-derived suppressor cells are more prevalent in patients treated with statins or with advanced carotid atherosclerosis requiring endarterectomy
Acta Angiologica · 2025
DOI: 10.5603/aa.105599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Angiologica, 2025. Verfasst von Michał Konrad Zarobkiewicz und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zarobkiewicz, M. K., Dąbrowska, I., Kowalska, W., Lehman, N., Szymańska, A., Wolski, A., & Bojarska-Junak, A. (2025). Monocytic myeloid-derived suppressor cells are more prevalent in patients treated with statins or with advanced carotid atherosclerosis requiring endarterectomy. Acta Angiologica. https://doi.org/10.5603/aa.105599
Vancouver
Zarobkiewicz MK, Dąbrowska I, Kowalska W, Lehman N, Szymańska A, Wolski A, et al. Monocytic myeloid-derived suppressor cells are more prevalent in patients treated with statins or with advanced carotid atherosclerosis requiring endarterectomy. Acta Angiologica. 2025. doi:10.5603/aa.105599
BibTeX
@article{Zarobkiewicz2025,
author = {Zarobkiewicz, Michał Konrad and Dąbrowska, Izabela and Kowalska, Wioleta and Lehman, Natalia and Szymańska, Agata and Wolski, Andrzej and Bojarska-Junak, Agnieszka},
title = {Monocytic myeloid-derived suppressor cells are more prevalent in patients treated with statins or with advanced carotid atherosclerosis requiring endarterectomy},
journal = {Acta Angiologica},
year = {2025},
doi = {10.5603/aa.105599}
}
EUVIMED